Literature DB >> 9356172

Dorsal determinants in the Xenopus egg are firmly associated with the vegetal cortex and behave like activators of the Wnt pathway.

Y Marikawa1, Y Li, R P Elinson.   

Abstract

The Xenopus egg contains maternal dorsal determinants that are specifically located at the vegetal cortex. To study physical and functional properties of the dorsal determinants, we took advantage of the animal-vegetal reversed embryo. The animal-vegetal reversed embryo is produced by inversion of the fertilized egg, which results in formation of ectoderm and endoderm from the unpigmented and the pigmented halves, respectively [Neff et al. (1983). Dev. Biol. 97, 103-112; Black and Gerhart (1985). Dev. Biol. 108, 310-324]. We demonstrated by cytoplasmic transplantation that the dorsal activity was specifically localized to the unpigmented cortical cytoplasm of the inverted egg, which is segregated into the future ectodermal lineage. This result suggests that the dorsal determinants are associated with the unpigmented cortex and are not dislodged by the inversion. In addition, we found that two vegetally localized transcripts, Xcat2 and Vg1 mRNAs, were present in the reversed animal pole of the inverted egg, suggesting their association with the unpigmented cortex. In order to compare the dorsal determinant activity with known dorsalizing molecules, we examined the expression pattern of Xnr3 and Siamois in the reversed embryo because these two genes are activated by the Wnt-pathway activators (Xwnt-8, beta-catenin, etc.) but not by other dorsalizing molecules (noggin, BVg1, etc.). Animal cap of the reversed embryo, which received the unpigmented cortex of the egg, expressed Xnr3 and Siamois. However, Mix.1, a marker expressed in endoderm and mesoderm in the normal embryo in response to mesodermal inducers, was not detected in the animal cap of the reversed embryo. In addition, we found that beta-catenin protein accumulated in nuclei of unpigmented animal pole cells of the reversed embryo. These results suggest that the maternal dorsal determinants behave more similarly to the Wnt-pathway activators than noggin or BVg1. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356172     DOI: 10.1006/dbio.1997.8710

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  7 in total

1.  beta-Catenin is essential for patterning the maternally specified animal-vegetal axis in the sea urchin embryo.

Authors:  A H Wikramanayake; L Huang; W H Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

2.  Parallel microtubules and other conserved elements of dorsal axial specification in the direct developing frog, Eleutherodactylus coqui.

Authors:  Richard P Elinson; Hiromasa Ninomiya
Journal:  Dev Genes Evol       Date:  2002-12-13       Impact factor: 0.900

3.  Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.

Authors:  G H Farr; D M Ferkey; C Yost; S B Pierce; C Weaver; D Kimelman
Journal:  J Cell Biol       Date:  2000-02-21       Impact factor: 10.539

4.  Single blastomere expression profiling of Xenopus laevis embryos of 8 to 32-cells reveals developmental asymmetry.

Authors:  Monika Flachsova; Radek Sindelka; Mikael Kubista
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

5.  Asymmetric Localization of CK2α During Xenopus Oogenesis.

Authors:  Gregory A Imbrie; Hao Wu; David C Seldin; Isabel Dominguez
Journal:  Hum Genet Embryol       Date:  2012-05-05

6.  Vegetally localized Xenopus trim36 regulates cortical rotation and dorsal axis formation.

Authors:  Tawny N Cuykendall; Douglas W Houston
Journal:  Development       Date:  2009-08-12       Impact factor: 6.862

7.  Maternal Dead-End1 is required for vegetal cortical microtubule assembly during Xenopus axis specification.

Authors:  Wenyan Mei; Zhigang Jin; Fangfang Lai; Tyler Schwend; Douglas W Houston; Mary Lou King; Jing Yang
Journal:  Development       Date:  2013-04-24       Impact factor: 6.862

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.